Economic Burden of Huntington’s Disease in China: Results from a National-Wide Cross-Sectional Study
Neuroepidemiology · 2024
DOI: 10.1159/000534564 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Neuroepidemiology, 2024. Verfasst von Shanquan Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Centre for Evidence in Disability, London School of Hygiene and Tropical Medicine, London, UK. Hauptthemen laut MEDLINE: Huntington Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Huntington’s disease (HD) poses a significant socio-economic burden globally. Existing research on HD’s economic burden predominantly comes from Western settings, leaving a gap in data from Asian countries. This study aimed to assess the economic burden of HD in China and identify cost-driving factors.
Methods
This study used data from a 2019 nationwide cross-sectional survey of individuals affected by rare diseases in China. Data included socio-demographic characteristics, income, disease stage, health and social insurance coverage status, treatment-seeking behaviour, and costs. Logistic regression and linear regression were used to explore potential contributors to treatment-seeking behaviour and associated costs.
Results
Of the 269 individuals with HD included in this study, 80.6% were actively seeking treatment. The average annual direct medical cost, direct non-medical cost, and indirect cost were 3,265.65, 805.82, and 801.97 Euros, respectively. Compared to participants with early-stage HD, those with middle- or advanced-stage HD reported higher direct medical costs (coefficient 1,612.70, 95% confidence interval [CI]: [141.92, 3,083.48] and 2,398.58, 95% CI: [791.16, 4,006.00], respectively). However, the disease stage was not significantly associated with direct non-medical costs or indirect costs.
Conclusions
This study provides crucial insights into the economic burden of HD in China. It emphasises a need for targeted policies that better cater to the financial needs of HD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- International Centre for Evidence in Disability, London School of Hygiene and Tropical Medicine, London, UK.
- Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China, hyzhang@cuhkri.org.cn.
- Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Chinese HD Association, Pudong District, Shanghai, China.
- Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China.
Zitieren
APA
Chen, S., Zhang, H., Yu, J., Cao, X., Zhang, S., & Dong, D. (2024). Economic Burden of Huntington’s Disease in China: Results from a National-Wide Cross-Sectional Study. Neuroepidemiology. https://doi.org/10.1159/000534564
Vancouver
Chen S, Zhang H, Yu J, Cao X, Zhang S, Dong D. Economic Burden of Huntington’s Disease in China: Results from a National-Wide Cross-Sectional Study. Neuroepidemiology. 2024. doi:10.1159/000534564
BibTeX
@article{Chen2024,
author = {Chen, Shanquan and Zhang, Huanyu and Yu, Jiazhou and Cao, Xi and Zhang, Shuyang and Dong, Dong},
title = {Economic Burden of Huntington’s Disease in China: Results from a National-Wide Cross-Sectional Study},
journal = {Neuroepidemiology},
year = {2024},
doi = {10.1159/000534564}
}
EUVIMED